Conference Coverage

Diabetic neuropathic pain linked to brain bioenergic anomalies

Publish date: October 19, 2020

 

FROM EASD 2020

SOURCE: Sloan S et al. EASD 2020, oral presentation 181.

Pages

Recommended Reading

ED visits for life-threatening conditions declined early in COVID-19 pandemic
MDedge Neurology
Daily Recap: ED visits for life-threatening conditions plummet; COVID-19 imaging strategies for kids
MDedge Neurology
Cognitive deficits complex in youths with type 2 diabetes
MDedge Neurology
Captopril questioned for diabetes patients in COVID-19 setting
MDedge Neurology
Daily Recap: Lifestyle vs. genes in breast cancer showdown; Big pharma sues over insulin affordability law
MDedge Neurology
Good for profits, good for patients: A new form of medical visits
MDedge Neurology
Does metformin reduce risk for death in COVID-19?
MDedge Neurology
Vascular dementia risk particularly high in type 2 diabetes
MDedge Neurology
Smart health devices – promises and pitfalls
MDedge Neurology
Geriatric patients: My three rules for them
MDedge Neurology